Obesity is a key therapeutic area for Pfizer, and the company has a robust pipeline of three clinical and several pre-clinical candidates, Mikael Dolsten, MD, the chief scientific officer and president of research and development at Pfizer, said in a statement about the new drug
These agents work in the same pathway as DPP-4 inhibitors but are generally considered more potent
Abstract Purpose: The study aimed to explore the effects of l-carnitine, acetyl-l-carnitine, and propionyl-l-carnitine on Body Mass in type 2 diabetes mellitus (T2DM) patients
FOXO3a acetylation regulates PINK1, mitophagy, inflammasome activation in murine palmitate-conditioned and diabetic macrophages
doi: 10.1074/jbc.M109.047605 61
Store BPC-157 capsules in a cool, dry place, away from direct light and moisture